Professor Marcia Langton is a researcher and commentator on Australian Indigenous issues, including land rights, native title, natural resources and corporate social responsibility.
Associate Professor Andrew Hill
0425 784 778
Ryan Sheales (media office)
0402 351 412
Using newly available genetic sequencing scientists discovered cells infected with prions (the infectious agent responsible for these diseases) release particles which contain easily recognized ‘signature genes’.
Associate Professor Andrew Hill — from the Department of Biochemistry and Molecular Biology at the Bio21 Institute — said these particles travel in the blood stream, making a diagnostic blood test a possibility.
“This might provide a way to screen people who have spent time in the UK, who currently face restrictions on their ability to donate blood,” he said.
“With a simple blood test nurses could deem a prospective donor’s blood as healthy, with the potential to significantly boost critical blood stocks.”
Mad Cow disease was linked to the deaths of nearly 200 people in Great Britain who consumed meat from infected animals in the late 1980s.
Since 2000, the Australia Red Cross Blood Service has not accepted blood from anybody who lived in the UK for more than six months between 1980 and 1996, or who received a blood transfusion in the UK after 1980.
The research is published in this week’s Oxford University Press Nucleic Acids Research journal.
Lead author Dr Shayne Bellingham said the breakthrough might also help detect other human neurodegenerative diseases, such as Alzheimer’s and Parkinson’s.
“This is an exciting new field where we can test for conditions in the brain and throughout the body, without being invasive,” he said.
The researchers’ genetic testing focused on a form of cell discharge called exosomes.
If exosomes were infected with prions (the pathogen that causes Creutzfeldt-Jakob Disease and Bovine Spongiform Encephalopathy, commonly known as Mad Cow Disease) they were found to also carry a specific signature of small genes called microRNA’s.
The research was undertaken at the University of Melbourne, with assistance from the Mental Health Research Institute of Victoria, the National Health and Medical Research Council and the Australian Research Council.